•Ä‘—§Œ’NŠÂ‹«‰ÈŠwŒ¤‹†ŠƒWƒƒ[ƒiƒ‹
EHP 119(7) 2011”N7ŒŽ† Correspondence ƒƒ`ƒ‹…‹â‚̊‹«Œ’NŒ¤‹†‚ÌŽ¦´ ’Óc•qGAû®“¡‹MŽuAŒ´“c³ƒ î•ñŒ¹FEHP 119(7) Jul 2011 Correspondence Environmental Health Research Implications of Methylmercury Toshihide Tsuda, Takashi Yorifuji, Masazumi Harada Department of Environmental Epidemiology, Okayama University Graduate School of Environmental Science, Okayama, Japan, E-mail: tsudatos@md.okayama-u.ac.jp, Department of Epidemiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, Department of Social Welfare Studies, Kumamoto Gakuen University, Kumamoto, Japan Citation: Tsuda T, Yorifuji T, Harada M 2011. Environmental Health Research Implications of Methylmercury. Environ Health Perspect 119:a284-a284. doi:10.1289/ehp.1103580 Online: 01 July 2011 http://ehp03.niehs.nih.gov/article/fetchArticle.action?articleURI=info%3Adoi%2F10.1289%2Fehp.1103580 T.T. and M.H. have provided expert testimony on Minamata disease. The other author declares he has no actual or potential competing financial interests. iT.T. ‚Æ M.H. ‚ÍA…–“•a‚ÉŠÖ‚·‚éê–å‰ÆØŒ¾‚ðs‚È‚Á‚½B ‘¼‚Ì’˜ŽÒ‚ÍAŽÀÛ‚É–”‚ÍöÝ“I‚Éà“I—˜ŠQŠÖŒW‚É’ïG‚µ‚È‚¢‚±‚Æ‚ð錾‚·‚éBj –óFˆÀŠÔ@•@i‰»Šw•¨Ž¿–â‘èŽs–¯Œ¤‹†‰ïj http://www.ne.jp/asahi/kagaku/pico/ ŒfÚ“úF2011”N7ŒŽ2“ú ‚±‚̃y[ƒW‚ւ̃Šƒ“ƒNF http://www.ne.jp/asahi/kagaku/pico/mercury/research/EHP_July_2011_Methylmercury.html @wƒƒ`ƒ‹…‹â‚Ì—LŠQ‰e‹¿FŠÂ‹«Œ’NŒ¤‹†‚ÌŽ¦´ EHP 118(8) 2010”N8ŒŽiAdverse Effects of Methylmercury: Environmental Health Research Implicationsj‚Ì’†‚ÅAGrandjean et al. (2010) i–ó’1jx‚ÍA…–“•aŽ–Œ‚Ì—ðŽj‚ðŠÜ‚ñ‚Ńƒ`ƒ‹…‹â”˜˜I‚©‚ç‚à‚½‚炳‚ê‚錒NƒŠƒXƒN‚̉Ȋw“I”Œ©‚ðƒŒƒrƒ…[‚µ‚½B”Þ“™‚Ì•\‘è‚ÍAhŒ¤‹†‚ÌŽ¦´iresearch implicationsjh‚Å‚ ‚邪A’˜ŽÒ“™‚ÍŽ–Œ‚©‚ç‚Ì‚¢‚‚‚©‚Ìd—v‚ÈŒx‚ð“`‚¦‚Ä‚¢‚È‚¢B @‘æˆê‚ÉAGrandjean et al. (2010)‚ÍA‚±‚ÌŽ–Œ‚ª‚ ‚½‚©‚àh³Šm‚ÈŒ´ˆöiƒƒ`ƒ‹…‹âjh‚̳Ž®‚È”F’m‚Ìd‘å‚È’x‚ꂪ‘Ήž‘[’u‚ð’x‚点‚½‚悤‚Éà–¾‚µ‚Ä‚¢‚éB‚µ‚©‚µA•aˆö•¨Ž¿‚Ì”F’m‚Í—\–h‚É‚Æ‚Á‚Ä•K—vðŒ‚Å‚Í‚È‚¢(Goodman et al. 1990)B‚½‚Æ‚¦•aˆö•¨Ž¿‚ª‚í‚©‚ç‚È‚‚Ä‚àA”˜˜IŒ¹‚Æ“`’B‚ª“Á’肳‚ê‚ê‚ÎA‚»‚ê‚ç‚ÍŽæ‚蜂©‚ê‚È‚‚Ä‚Í‚È‚ç‚È‚¢B…–“•a‚ÌꇂɂÍAʼn‚ÌŠ³ŽÒ‚ª“Á’肳‚ꂽ1956”N‚É‚Í‚·‚Å‚ÉA‰˜õ‚³‚ꂽŠCŽY•¨‚ðÛH‚·‚邱‚Æ‚ª•a‹C‚ÌŒ´ˆö‚Å‚ ‚邱‚Æ‚Í”»–¾‚µ‚Ä‚¢‚½B‚»‚ê‚Í•aˆö•¨Ž¿‚ª“Á’肳‚ê‚é3”N‘O‚Ì‚±‚Æ‚Å‚ ‚Á‚½(Tsuda et al. 2009)BGrandjean “™i2010j‚ÍAHarada (2004)‚ðˆø—p‚µ‚½‚ªA”Þ‚ÍŽŸ‚̂悤‚É‘‚¢‚½B
@‘æ“ñ‚ÉAGrandjean et al. (2010)‚ÍAƒƒ`ƒ‹…‹â’†“ÅŽ–Œ‚Ìhf’f‚Ì¢“h‚ðq‚ׂĂ¢‚éBH’†“Å‚Æ‚µ‚Ä‚Ì…–“•aŽ–Œ‚Ì’²¸‚ÌŒ‡”@‚ª•s•K—v‚Èf’f‚Ì¢“ï‚ð‚à‚½‚炵‚½B‚»‚̂悤‚È¢“‚ÍA’ÊíA“ú–{‚É‚¨‚¯‚éH’†“ÅŽ–Œ‚łͶ‚¶‚È‚¢B…–“•a‚ÌꇂɂÍA1977”N‚ÉA“ú–{‚̊‹«ÈiJMEj‚Íf’fŠî€‚ðŠm—§‚µ‚½‚ªA‚»‚ê‚ÍJME‚É‚æ‚Á‚Ä¥‚¦‚ç‚ꂽAˆãŠw“I‚É‚Í’ù³‚³‚ê‚é‚ׂ«AÇó‚Ì‘g‚݇‚킹‚ð‹‚ß‚é‚à‚Ì‚Å‚ ‚éB‚µ‚©‚µŽ–ŽÀ‚ÍAJME‚͊ɈãŠw“IØ‹’‚ªŒ‡”@‚µ‚Ä‚¢‚邱‚Æ‚ð”F‚ß‚Ä‚¢‚½‚Æ‚¢‚¤‚±‚Æ‚Å‚ ‚é [Committee on Research and Human Rights/Japanese Society and Psychiatry and Neurology (CRHR-JSPN) 2003]B‚³‚ç‚ÉA“ú–{‚̈ãŠwŒ¤‹†ŽÒ‚炪A‚»‚̊͈ãŠw“I‚ÉŠÔˆá‚Á‚Ä‚¢‚é‚ÆŽw“E‚µ‚Ä‚¢‚½(CRHR-JSPN 1998)Bhf’f‚Ì¢“h‚Í‚¨‚»‚ç‚A’N‚ª‰e‹¿‚ðŽó‚¯_ŒoŠw“I’›Œó‚ðŽ‚Á‚Ä‚¢‚½‚Ì‚©‚ðžB–†‚É‚µ‚½‚Å‚ ‚낤B @‘æŽO‚ÉAGrandjean et al. (2010)‚ÍAh2009”N‚ÉA”íŠQŽÒ‚ÌŽc‚è‚̃Oƒ‹[ƒv‚Ì‚Ù‚Æ‚ñ‚Ç‚ÌlX‚É•âž‚ð—^‚¦‚éiprovide compensationj‚½‚ß‚Ì–@—¥‚ª§’肳‚ꂽh‚Æq‚ׂĂ¢‚éB‚µ‚©‚µA‚»‚ê‚Í•âžicompensationj‚Å‚Í‚È‚¢B…–“•a‚ɂ‚¢‚ÄA‰e‹¿‚ðŽó‚¯‚½lX‚ªãq‚̊ɂæ‚Á‚Äf’f‚³‚ê‚È‚¯‚ê‚ÎA”Þ“™‚ÍŠ³ŽÒ‚Æ‚µ‚ÄŠ¨’è‚É“ü‚ê‚ç‚ꂸA]‚Á‚Ä“KØ‚É•âž‚³‚ê‚È‚¢B–ñ2,200l‚ª…–“•a‚Æ‚µ‚Äf’f‚³‚êA•âž‚³‚ê‚Ä‚¢‚½‚ªAƒƒ`ƒ‹…‹â’†“Å‚Ì_ŒoŠw“IÇó‚Ì“Á’¥‚ðŽ‚‚Ȃ‚Æ‚à”–œl‚Ì”íŠQŽÒ‚ªŠ³ŽÒ‚Æ‚µ‚Ä”F‚ß‚ç‚ꂸA“KØ‚É•âž‚³‚ê‚Ä‚¢‚È‚¢(McCurry 2006)B @‘æŽl‚ÉAGrandjean et al. (2010)‚ÍA1959”N‚̃lƒR‚ÌŽÀŒ±‚ÌA40”N’x‚ê‚Ä”•\‚³‚ꂽh‰ÈŠw“Id—v«h‚ðq‚ׂĂ¢‚é(Eto et al. 2001)B‚µ‚©‚µA‚±‚Ì•ñ‘‚ÍA•a—Šw“I”Œ©‚¾‚¯‚ð’ñ‹Ÿ‚µ‚Ä‚¨‚èAƒlƒR‚ÌŽÀŒ±‚ÌÚׂÈà–¾‚Í‚·‚Å‚É1965”N‚É”•\‚³‚ê‚Ä‚¢‚½(Tomita 1965)BŒãŽÒ‚Ì‚à‚Ì‚ª—\–h‚ÆŠÇ—‚Ì‚½‚ß‚É‚Í\•ª‚Å‚ ‚Á‚½‚Å‚ ‚낤B @ÅŒã‚ÉAJME‚ÆŽ©Ž¡‘Ì‚Í…–“•a‘iׂ̔í‚Å‚ ‚Á‚½‚½‚ß‚ÉAJME‚ÆŽ©Ž¡‘Ì‚©‚ço‚½Œ¤‹†Ž‘‹à‚ÍA‚±‚Æ‚É‚æ‚é‚Æ—˜‰v‘Š”½iconflicts of interestj‚ðˆø‚«‹N‚±‚µAŒ¤‹†ŽÒ‚Ì‘Ô“x‚ɉe‹¿‚ð—^‚¦‚½‚©‚à‚µ‚ê‚È‚¢B References CRHR-JSPN (Committee on Research and Human Rights/Japanese Society and Psychiatry and Neurology) 1998. An opinion on the criteria on acquired Minamata disease Psychiatr Neurol Jpn 100:765?790. Find this article online CRHR-JSPN (Committee on Research and Human Rights/Japanese Society and Psychiatry and Neurology). 2003. An opinion about Minamata disease accreditation system and medical specialistsf involvement [in Japanese]. Psychiatr Neurol Jpn105:809?834. Eto K, Yasutake A, Nakano A, Akagi H, Tokunaga H, Kojima T.. 2001. Reappraisal of the historic 1959 cat experiment in Minamata by the Chisso factory. Tohoku J Exp Med 194(4):197?203. Find this article online Goodman RA, Buehler JW, Koplan JP. 1990. The epidemiologic field investigation: science and judgment in public health practice. Am J Epidemiol 132:91?96. Find this article online Grandjean P, Satoh H, Murata K, Eto K.. 2010. Adverse effects of methylmercury: envionmental health research implications. Environ Health Perspect 118:1137?1145. Find this article online Harada M. 2004. Minamata Disease (Sachie T, George TS, translators). Tokyo:Iwanami Shoten. McCurry J.. 2006. Japan remembers Minamata. Lancet 367:99?100. Find this article online Tomita H.. 1965. Minamata disease 12 Goka 7:346?353. Find this article online Tsuda T, Yorifuji T, Takao S, Miyai M, Babazono A.. 2009. Minamata disease: catastrophic poisoning due to a failed public health response. J Public Health Policy 30:54?67. Find this article online –ó’1 EHP 118(8) 2010”N8ŒŽ†@ƒƒ`ƒ‹…‹â‚Ì—LŠQ‰e‹¿FŠÂ‹«Œ’NŒ¤‹†‚ÌŽ¦´ http://www.ne.jp/asahi/kagaku/pico/mercury/research/EHP_Aug_2010_Methylmercury_Lessons_Learned.html EHP_118(8)_Aug_2010 Adverse Effects of Methylmercury: Environmental Health Research Implications http://ehp03.niehs.nih.gov/article/fetchArticle.action?articleURI=info%3Adoi%2F10.1289%2Fehp.0901757 –ó’2iŽQlj ‘—§…–“•a‘‡Œ¤‹†ƒZƒ“ƒ^[ u…–“•a‚ÉŠÖ‚·‚éŽÐ‰ï‰ÈŠw“IŒ¤‹†‰ïv•ñ‘ …–“•a‚̔ߌ€‚ðŒJ‚è•Ô‚³‚È‚¢‚½‚ß‚É |…–“•a‚ÌŒoŒ±‚©‚çŠw‚Ô‚à‚Ì| •½¬11”N12ŒŽ@…–“•a‚ÉŠÖ‚·‚éŽÐ‰ï‰ÈŠw“IŒ¤‹†‰ï ‘æ2Í@…–“•a‚ÌŒ´ˆö‹†–¾‹y‚Ñ”¶Œ¹Šm’è‚̉ߒöi‚»‚Ì1jiPDF”Å33ƒy[ƒWj http://www.nimd.go.jp/syakai/webversion/pdfversion/028041_2shou.pdf uEEEŒ§‰q¶•”‚ÍAH•i‰q¶–@‘æ4ð‘æ2†‚Ì‹K’è‚É€‚¶‚½ó‹µ‚Å‚ ‚é‚Æ”»’f‚µA•ßŠl‚âÛH‚ð‹Ö‚¶‚é’mŽ–Ž¦‚ðo‚·‚Æ‚¢‚¤•ûj‚ðŒˆ‚ßA“¯”N8ŒŽ16“úAŒú¶È‚ÉH•i‰q¶–@‚Ì“K—p‚̉”ۂðƉ‚½B @‚Æ‚±‚낪A“¯”N9ŒŽ11“úAŒú¶ÈŒöO‰q¶‹Ç’·‚©‚çŒF–{Œ§’mŽ–‚É“Í‚¢‚½‰ñ“š‚ÍAu…–“˜p“Á’è’nˆæ‚Ì‹›‰î—Þ‚ðÛH‚·‚邱‚Æ‚ÍAŒ´ˆö•s–¾‚Ì’†•«_ŒoŽ¾Š³‚𔶂³‚¹‚邨‚»‚ꂪ‚ ‚é‚Ì‚ÅA¡Œã‚Æ‚à…–“˜p‚Ì‹›‰î—Þ‚ªÛŽæ‚³‚ê‚È‚¢‚悤Žw“±‚·‚邱‚ÆB‘R‚µA…–“˜p“à“Á’è’nˆæ‚Ì‹›‰î—Þ‚Ì‚·‚ׂĂª—L“ʼn»‚µ‚Ä‚¢‚é‚Æ‚¢‚¤–¾‚ç‚©‚Ȫ‹’‚ª”F‚ß‚ç‚ê‚È‚¢‚Ì‚ÅA“–ŠY“Á’è’nˆæ‚É‚Ä‹™Šl‚³‚ꂽ‹›‰î—Þ‚Ì‚·‚ׂĂɑ΂µH•i‰q¶–@‘æ4ð‘æ2†‚ð“K—p‚·‚邱‚Æ‚Í‚Å‚«‚È‚¢‚à‚Ì‚Æl‚¦‚év‚Æ‚¢‚¤‚à‚Ì‚Å‚ ‚Á‚½BEEEv |